Danaher | DHR - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio Techne USD 2.55B 27.9M 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.23B 200M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
ESCO Technologies USD 2.41B 6.81M 2026-03
Fortive USD 11.58B 153.6M 2026-03
Henry Schein USD 11.3B 89M 2026-03
Illumina USD 6.56B 85M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 29.68B 269M 2026-03
Keysight Technologies USD 11.74B 257M 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Medtronic USD 91.48B 139M 2025-12
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Quest Diagnostics USD 16.94B 266M 2026-06
Quidel USD 5.63B 140.6M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
Roper Industries USD 35.17B 618.7M 2026-06
Stryker USD 46.29B 1.55B 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Waters USD 24.53B 19.45B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03